Substance Use Treatment
In 2024, the Substance Abuse and Mental Health Services Administration (SAMHSA) reported that 48.4 million individuals aged 12 and older (approximately 16.8% of the population) had experienced a substance use disorder (SUD). The percentage of people 12 or older with a drug use disorder in the past year increased from 8.7% in 2021 to 9.8% in 2024. This highlights the urgent need for comprehensive and continuous care for individuals living with SUDs.
Evidence-based.
Magellan recognizes substance use disorders as chronic conditions—and seeks to coordinate with you to reduce the likelihood of acute events. In this section of our site, you'll learn more about our evidence-based approach that forms the cornerstone of all of our efforts to serve members battling substance use disorders, including opioid use disorder.
Integrated.
Our approach includes:
- Medication-assisted treatment with the most-effective pharmacological remedies available
- Care management
- Clinical interventions
- Personalized substance use coaching
- Provider education
- Improved member self-management.
Innovative.
Learn more about:
-
Screening, Brief Intervention, and Referral to Treatment (SBIRT)
-
Initiation and Engagement of Alcohol and Other Drug (AOD) Abuse or Dependence Treatment (IET)
Reference:
Substance Abuse and Mental Health Services Administration. 2025. “Key Substance Use and Mental Health Indicators in the United States: Results from the 2024 National Survey on Drug Use and Health.” HHS Publication No. PEP25-07-007, NSDUH Series. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data/